Pfizer
Pfizer's $11-bn share repurchase ends chances of renewed bid for AstraZeneca
25 Oct 2014
US drugmaker Pfizer’s board yesterday authorised a new $11-billion share repurchase plan, which analysts say puts an end to speculations that it would renew its bid for British rival AstraZeneca
Pfizer’s anti-smoking drug Chantix to carry black-box waning till availability of study data
17 Oct 2014
US judge upholds Ranbaxy-Pfizer Lipitor marketing deal
13 Sep 2014
In a piece of good news for the US FDA-challenged Ranbaxy laboratories, a US court has dismissed an anti-trust suit against Pfizer Inc and India's Ranbaxy that accused them of conspiring to delay sales of generic versions of the cholesterol drug Lipitor
Pfizer hit with lawsuits over Lipitor
11 Aug 2014
Collectis shares surge on Pfizer deal
19 Jun 2014
Pfizer drops AstarZeneca take over bid
28 May 2014
AstraZeneca rejects Pfizer’s third takeover offer
19 May 2014
AstraZeneca said that Pfizer’s tax-driven inversion structure, which is a key part of its proposal, has already been the subject of intense public and governmental scrutiny
